Harbor Capital Advisors Inc. Acquires 10,589 Shares of Phibro Animal Health Corporation (NASDAQ:PAHC)

Harbor Capital Advisors Inc. raised its stake in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) by 4,727.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,813 shares of the company's stock after acquiring an additional 10,589 shares during the quarter. Harbor Capital Advisors Inc.'s holdings in Phibro Animal Health were worth $231,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Millennium Management LLC raised its holdings in Phibro Animal Health by 233.0% in the fourth quarter. Millennium Management LLC now owns 207,749 shares of the company's stock worth $4,363,000 after purchasing an additional 145,359 shares during the period. Jacobs Levy Equity Management Inc. increased its position in shares of Phibro Animal Health by 56.7% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company's stock valued at $6,325,000 after buying an additional 108,918 shares in the last quarter. Hussman Strategic Advisors Inc. bought a new stake in shares of Phibro Animal Health in the 4th quarter valued at $2,205,000. Nuveen Asset Management LLC raised its stake in Phibro Animal Health by 21.4% during the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock worth $12,348,000 after buying an additional 103,618 shares during the period. Finally, Alliancebernstein L.P. lifted its holdings in Phibro Animal Health by 357.1% during the fourth quarter. Alliancebernstein L.P. now owns 130,000 shares of the company's stock worth $2,730,000 after acquiring an additional 101,560 shares in the last quarter. 99.34% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently weighed in on PAHC shares. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a report on Monday. Wall Street Zen raised Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Morgan Stanley upped their price objective on Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 8th. Finally, BNP Paribas Exane upgraded Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective for the company in a report on Monday. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $20.80.

Phibro Animal Health Stock Performance

Shares of PAHC traded down $0.21 during mid-day trading on Wednesday, reaching $24.25. The company's stock had a trading volume of 94,048 shares, compared to its average volume of 206,134. The company has a current ratio of 2.91, a quick ratio of 1.23 and a debt-to-equity ratio of 2.67. Phibro Animal Health Corporation has a 1-year low of $16.16 and a 1-year high of $26.55. The business has a 50-day simple moving average of $21.49 and a two-hundred day simple moving average of $21.91. The stock has a market cap of $982.65 million, a P/E ratio of 31.01, a PEG ratio of 0.47 and a beta of 0.74.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. The firm had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. As a group, equities research analysts anticipate that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be paid a $0.12 dividend. The ex-dividend date is Wednesday, June 4th. This represents a $0.48 annualized dividend and a yield of 1.98%. Phibro Animal Health's dividend payout ratio (DPR) is presently 61.54%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.